186 related articles for article (PubMed ID: 31332047)
1. Anticancer Immunotherapy by MFAP5 Blockade Inhibits Fibrosis and Enhances Chemosensitivity in Ovarian and Pancreatic Cancer.
Yeung TL; Leung CS; Yip KP; Sheng J; Vien L; Bover LC; Birrer MJ; Wong STC; Mok SC
Clin Cancer Res; 2019 Nov; 25(21):6417-6428. PubMed ID: 31332047
[TBL] [Abstract][Full Text] [Related]
2. CAFs-derived MFAP5 promotes bladder cancer malignant behavior through NOTCH2/HEY1 signaling.
Zhou Z; Cui D; Sun MH; Huang JL; Deng Z; Han BM; Sun XW; Xia SJ; Sun F; Shi F
FASEB J; 2020 Jun; 34(6):7970-7988. PubMed ID: 32293074
[TBL] [Abstract][Full Text] [Related]
3. Stromal fibroblast-derived MFAP5 promotes the invasion and migration of breast cancer cells via Notch1/slug signaling.
Chen Z; Yan X; Li K; Ling Y; Kang H
Clin Transl Oncol; 2020 Apr; 22(4):522-531. PubMed ID: 31190277
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance.
Leung CS; Yeung TL; Yip KP; Wong KK; Ho SY; Mangala LS; Sood AK; Lopez-Berestein G; Sheng J; Wong ST; Birrer MJ; Mok SC
J Clin Invest; 2018 Feb; 128(2):589-606. PubMed ID: 29251630
[TBL] [Abstract][Full Text] [Related]
5. Targeting MFAP5 in cancer-associated fibroblasts sensitizes pancreatic cancer to PD-L1-based immunochemotherapy via remodeling the matrix.
Duan Y; Zhang X; Ying H; Xu J; Yang H; Sun K; He L; Li M; Ji Y; Liang T; Bai X
Oncogene; 2023 Jun; 42(25):2061-2073. PubMed ID: 37156839
[TBL] [Abstract][Full Text] [Related]
6. Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts.
Moatassim-Billah S; Duluc C; Samain R; Jean C; Perraud A; Decaup E; Cassant-Sourdy S; Bakri Y; Selves J; Schmid H; Martineau Y; Mathonnet M; Pyronnet S; Bousquet C
Oncotarget; 2016 Jul; 7(27):41584-41598. PubMed ID: 27177087
[TBL] [Abstract][Full Text] [Related]
7. MFAP5 suppression inhibits migration/invasion, regulates cell cycle and induces apoptosis via promoting ROS production in cervical cancer.
Li Q; Zhang Y; Jiang Q
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):51-58. PubMed ID: 30454902
[TBL] [Abstract][Full Text] [Related]
8. MFAP5 promotes tumor progression and bone metastasis by regulating ERK/MMP signaling pathways in breast cancer.
Wu Z; Wang T; Fang M; Huang W; Sun Z; Xiao J; Yan W
Biochem Biophys Res Commun; 2018 Apr; 498(3):495-501. PubMed ID: 29526753
[TBL] [Abstract][Full Text] [Related]
9. Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer.
Ogier C; Colombo PE; Bousquet C; Canterel-Thouennon L; Sicard P; Garambois V; Thomas G; Gaborit N; Jarlier M; Pirot N; Pugnière M; Vie N; Gongora C; Martineau P; Robert B; Pèlegrin A; Chardès T; Larbouret C
Cancer Lett; 2018 Sep; 432():227-236. PubMed ID: 29935372
[TBL] [Abstract][Full Text] [Related]
10. Proteomic Analysis of Cancer-Associated Fibroblasts Reveals a Paracrine Role for MFAP5 in Human Oral Tongue Squamous Cell Carcinoma.
Principe S; Mejia-Guerrero S; Ignatchenko V; Sinha A; Ignatchenko A; Shi W; Pereira K; Su S; Huang SH; O'Sullivan B; Xu W; Goldstein DP; Weinreb I; Ailles L; Liu FF; Kislinger T
J Proteome Res; 2018 Jun; 17(6):2045-2059. PubMed ID: 29681158
[TBL] [Abstract][Full Text] [Related]
11. Microfibril Associated Protein 5 (MFAP5) Is Related to Survival of Ovarian Cancer Patients but Not Useful as a Prognostic Biomarker.
Kujawa KA; Zembala-Nożynska E; Syrkis JP; Cortez AJ; Kupryjańczyk J; Lisowska KM
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555638
[TBL] [Abstract][Full Text] [Related]
12. Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15
Dominguez CX; Müller S; Keerthivasan S; Koeppen H; Hung J; Gierke S; Breart B; Foreman O; Bainbridge TW; Castiglioni A; Senbabaoglu Y; Modrusan Z; Liang Y; Junttila MR; Klijn C; Bourgon R; Turley SJ
Cancer Discov; 2020 Feb; 10(2):232-253. PubMed ID: 31699795
[TBL] [Abstract][Full Text] [Related]
13. Microfibril-associated protein 5 and the regulation of skin scar formation.
Han C; Leonardo TR; Romana-Souza B; Shi J; Keiser S; Yuan H; Altakriti M; Ranzer MJ; Ferri-Borgogno S; Mok SC; Koh TJ; Hong SJ; Chen L; DiPietro LA
Sci Rep; 2023 May; 13(1):8728. PubMed ID: 37253753
[TBL] [Abstract][Full Text] [Related]
14. Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential.
Leung CS; Yeung TL; Yip KP; Pradeep S; Balasubramanian L; Liu J; Wong KK; Mangala LS; Armaiz-Pena GN; Lopez-Berestein G; Sood AK; Birrer MJ; Mok SC
Nat Commun; 2014 Oct; 5():5092. PubMed ID: 25277212
[TBL] [Abstract][Full Text] [Related]
15. Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer.
Yeung TL; Sheng J; Leung CS; Li F; Kim J; Ho SY; Matzuk MM; Lu KH; Wong STC; Mok SC
J Natl Cancer Inst; 2019 Mar; 111(3):272-282. PubMed ID: 29860390
[TBL] [Abstract][Full Text] [Related]
16. MFAP5 facilitates the aggressiveness of intrahepatic Cholangiocarcinoma by activating the Notch1 signaling pathway.
Li JH; Zhu XX; Li FX; Huang CS; Huang XT; Wang JQ; Gao ZX; Li SJ; Xu QC; Zhao W; Yin XY
J Exp Clin Cancer Res; 2019 Nov; 38(1):476. PubMed ID: 31775892
[TBL] [Abstract][Full Text] [Related]
17. Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling.
Secq V; Leca J; Bressy C; Guillaumond F; Skrobuk P; Nigri J; Lac S; Lavaut MN; Bui TT; Thakur AK; Callizot N; Steinschneider R; Berthezene P; Dusetti N; Ouaissi M; Moutardier V; Calvo E; Bousquet C; Garcia S; Bidaut G; Vasseur S; Iovanna JL; Tomasini R
Cell Death Dis; 2015 Jan; 6(1):e1592. PubMed ID: 25590802
[TBL] [Abstract][Full Text] [Related]
18. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
[TBL] [Abstract][Full Text] [Related]
19. Cancer-Associated Fibroblasts in Pancreatic Cancer: Should They Be Deleted or Reeducated?
Qu C; Wang Q; Meng Z; Wang P
Integr Cancer Ther; 2018 Dec; 17(4):1016-1019. PubMed ID: 30136592
[TBL] [Abstract][Full Text] [Related]
20. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
